Period1 Nov 2021

Media coverage

4

Media coverage

  • TitleGalmed declares positive results from Open-Label Part of ARMOR Phase 3 study in first 16 patients
    Media name/outletM2 Pharma
    Country/TerritoryUnited States
    Date1/11/21
    PersonsScott Friedman
  • TitleGalmed declares positive results from Open-Label Part of ARMOR Phase 3 study in first 16 patients
    Media name/outletM2Pharma.com
    Country/TerritoryUnited States
    Date1/11/21
    URLm2pharma.com/news/policy-and-regulations/article.php?id=94644
    PersonsScott Friedman
  • TitleGalmed declares positive results from Open-Label Part of ARMOR Phase 3 study in first 16 patients
    Media name/outletM2 EquityBites
    Country/TerritoryUnited Kingdom
    Date1/11/21
    PersonsScott Friedman
  • TitleGalmed declares positive results from Open-Label Part of ARMOR Phase 3 study in first 16 patients
    Media name/outletFinancialWire
    Country/TerritoryUnited Kingdom
    Date1/11/21
    PersonsScott Friedman